Galecto Biotech (private company)

See something wrong or missing? Let us know
Offices:Copenhagen
Business model:B2B

Galecto Biotech AB develops galectin modulators for the treatment of severe diseases, including fibrosis, cancer and inflammation

Investors: we tracked 11 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 153.64M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Galecto Biotech

Name Criteria
Norway Oncoinvent
73%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Hadean Ventures
  • At least one other investor: Canica AS
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
73%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Denmark AFYX Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Netherlands Citryll
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Seventure Partners
  • Total raised in a similar range: 10M+ USD
Denmark Draupnir Bio
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
France MaaT Pharma
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Seventure Partners
  • Total raised in a similar range: 10M+ USD
Denmark MinervaX
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures, Novo Seeds, Seed Capital
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Novo Seeds
  • Total raised in a similar range: 10M+ USD
Switzerland Synendos Therapeutics
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Sunstone Life Science Ventures
  • Total raised in a similar range: 10M+ USD
Germany Tubulis
63%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: Seventure Partners
  • Total raised in a similar range: 10M+ USD
Top